David Shaw’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$552K Buy
+14,500
New +$611K ﹤0.01% 4188

Other funds holding DFTX

David Shaw's DFTX Position: Q3 2026 in Review

David Shaw reduced its Definium Therapeutics (DFTX) stake by 49% in Q3 2026, selling an estimated $6.58M and leaving 159,305 shares worth $6.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2281.

David Shaw first reported a position in DFTX in Q2 2021 and has held it in 11 quarters since. The position peaked at $14.8M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • David Shaw held 159,305 shares of Definium Therapeutics worth $6.06M as of Q3 2026.
  • David Shaw sold 156,105 Definium Therapeutics shares in Q3 2026, an estimated $6.58M.
  • Definium Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #2281 holding.
  • David Shaw first reported a position in Definium Therapeutics in Q2 2021 and has held it in 11 quarters since.
  • David Shaw's Definium Therapeutics position peaked at $14.8M in Q2 2026.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.